Global Smart Syringes Market Insights Forecasts to 2033

• The Global Smart Syringes Market Size was Valued at USD 9.3 Billion in 2023.
• The Market Size is Growing at a CAGR of 8.22% from 2023 to 2033.
• The Worldwide Smart Syringes Market Size is Expected to Reach USD 20.5 Billion by 2033.
• Asia-Pacific is expected to Grow the fastest during the forecast period.

The Global Smart Syringes Market Size is Anticipated to Exceed USD 20.5 Billion by 2033, Growing at a CAGR of 8.22% from 2023 to 2033.

Market Overview

Smart syringes are medical devices with built-in safety features that prevent syringe reuse and regulate potentially dangerous injection techniques. They have features that prevent needlestick injuries and the spread of blood-borne infections such as hepatitis C virus (HCV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV) in those who use them. Furthermore, smart syringes include a built-in inactivation mechanism that protects against needle stick injuries, blood-borne infections such as hepatitis B and C, and the human immunodeficiency virus. They can handle a variety of applications, including vaccinations, medicine delivery, and blood collection. Depending on the application, various types of smart syringes are used, including auto-disable (AD) syringes, passive safety syringes, and active safety syringes. Additionally, the rising prevalence of chronic diseases and viral infections among the general population is one of the major factors driving up global demand for smart syringes. It can also be attributed to a growing elderly population, which is more vulnerable to serious medical conditions. Also, the growing number of blood-borne infections among the general population is boosting market growth. Aside from that, rising investments in healthcare infrastructure and medical services, along with extensive research and development (R&D), are expected to drive global smart syringes market growth.

Report Coverage

This research report categorizes the market for the global smart syringes market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global smart syringes market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global smart syringes market.

Driving Factors

The growing awareness of the risks associated with needlestick injuries, as well as the importance of healthcare worker safety, is driving demand for smart syringes. Needlestick injuries pose a significant risk to healthcare workers, resulting in infections and workplace hazards. The need to prevent such injuries is driving the adoption of smart syringes. Continuous advances in smart syringe technology, such as retractable needles, electronic safety mechanisms, and integrated data management systems, are boosting market growth.

Restraining Factors

The high cost of smart syringes compared to conventional syringes is a major impediment to market growth, particularly in developing countries with limited healthcare budgets. The lack of awareness and training among healthcare professionals about the benefits and applications of smart syringes hampers market expansion.

Market Segmentation

The global smart syringes market share is classified into product, application, and end user.

• The active safety syringes segment is expected to hold the largest share of the global smart syringes market during the forecast period.    

Based on the product, the global smart syringes market is categorized into auto-disable syringes, active safety syringes, and passive safety syringes. Among these, the active safety syringes segment is expected to hold the largest share of the global smart syringes market during the forecast period. The active safety syringe works with a syringe safety system that is activated by users or clinicians. Active safety systems are typically associated with shields or caps, which are devices that protect the needle after activation. These syringes' safety mechanism helps to reduce the number of needlestick injuries. Active safety syringes are more widely used than passive safety syringes and AD syringes due to their ease of use and safety features, which provide maximum protection to patients and healthcare employees, lowering the risk of needlestick injuries.

• The drug delivery segment is expected to grow at the fastest CAGR during the forecast period.  

Based on the application, the global smart syringes market is categorized into drug delivery, vaccination, and blood specimen collection. Among these, the drug delivery segment is expected to grow at the fastest CAGR during the forecast period. Syringes are commonly used to deliver desired drugs into patients' bodies. As a consequence, in many cases, injections are preferred over oral, topical, and inhaled drug delivery methods. Injectable drugs have better pharmacokinetics than other forms of dosage. During injections, both patients and caregivers are at risk of cross-infection and needle stick injuries. As a result, smart syringes are being used in drug delivery to avoid such risks, which in turn drives market growth.  

• The hospitals & HMOs segment is expected to hold the largest share of the global smart syringes market during the forecast period.     

Based on the end user, the global smart syringes market is categorized into hospitals & HMOs, diabetic patients, psychiatrists, and others. Among these, the hospitals & HMOs segment is expected to hold the largest share of the global smart syringes market during the forecast period. Smart syringes are widely used in public and private hospitals, multinational hospitals, and specialty hospitals for a variety of purposes including vaccination, drug delivery, blood specimen collection, and more. To prevent reuse, these hospitals, particularly those in developed countries, have mandated the use of smart syringes instead of conventional syringes. A Health Maintenance Organization (HMO) is a company that provides, arranges, or manages a variety of healthcare services for patients via a network of providers. Because smart syringes are covered by HMO plans, patients, doctors, and other healthcare workers can easily choose them over traditional syringes, even if they are more expensive.

Regional Segment Analysis of the Global Smart Syringes Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global smart syringes market over the predicted timeframe.

North America is projected to hold the largest share of the global smart syringes market over the forecast period due to the presence of a well-established healthcare infrastructure, increased purchasing power, and stringent regulations. Moreover, increased awareness of the risk of cross infections and needle stick injuries in the region led to increased use of safe syringes. Also, smart syringes play an important role in vaccinations because they aid in the prevention of seasonal and pandemic flu, thereby preventing disease spread caused by unsafe syringe practices. Furthermore, the Centers for Disease Control and Prevention (CDC) publishes a revised schedule of vaccinations recommended for the prevention of several diseases in the United States each year, which is expected to create favorable opportunities for domestic smart syringe manufacturers.

Asia-Pacific is expected to grow at the fastest CAGR growth of the global smart syringes market during the forecast period owing to factors such as a large patient pool, increased healthcare awareness, rise in healthcare expenditure, growth in disposable income, and government spending. Additionally, domestic companies are heavily involved in the production of low-cost smart syringes for both international and domestic markets. The regional market is expanding rapidly, due to an increase in needle stick injuries, increased regulatory awareness, improvements in health standards, a surge in disposable incomes, and technological advancements. In developing economies, the WHO and UN have implemented policies and standards for syringe procurement, disposal, and use. This leads to a recommendation strategy for safety syringe manufacturers to expand or begin production of these syringes as soon as possible while maintaining quality, safety, and performance standards in accordance with regulatory organizations. These factors are driving the smart syringes market in Asia-Pacific.   

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global smart syringes market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Becton, Dickinson and Company (BD)
• Baxter
• B. Braun Melsungen Ag
• Parker Hannifin Corp
• SCHOTT AG
• Cardinal Health, Inc.
• Smiths Medical (Smiths Group plc)
• Nipro Corporation
• Medtronic plc
• JMI Syringes & Medical Devices Limited
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• TERUMO CORPORATION
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In September 2022, Becton, Dickinson, and Company introduced a next-generation glass prefillable syringe that raises the standard for vaccine syringe performance by adding new and strengthened specifications for processability, contamination, and integrity.

• In August 2022, Baxter International Inc., a pioneer in breakthrough medicine delivery technology, announced FDA approval of its new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, which represents the company's most recent infusion therapy advancements.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global smart syringes market based on the below-mentioned segments:

Global Smart Syringes Market, By Product

• Auto Disable Syringes
• Active Safety Syringes
• Passive Safety Syringes

Global Smart Syringes Market, By Application

• Drug Delivery
• Vaccination
• Blood Specimen Collection

Global Smart Syringes Market, By End User

• Hospitals & HMOs
• Diabetic patients
• Psychiatrists
• Others

Global Smart Syringes Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa